Missouri
CNS clinical trials in Missouri
95 CNS studies are recruiting participants at sites in 15 cities across Missouri as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Missouri city with a recruiting study
By research area: Depression (30), Parkinson's Disease (17), Multiple Sclerosis (14), Schizophrenia (11), Migraine (10), Epilepsy (8), Bipolar Disorder (3), ADHD (2).
St Louis (69), Saint Charles (12), Kansas City (11), Springfield (6), City of Saint Peters (5), O'Fallon (5), Columbia (4), Chesterfield (2), Hazelwood (2), Ballwin (1), Creve Coeur (1), Lee's Summit (1), Osage Beach (1), Saint Joseph (1), Weldon Spring (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in Missouri
Basic details from each study's public record (the 12 most recently updated of 95). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- O'Fallon · Saint Charles
- Registry record
- NCT07226661 · updated
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Seaport Therapeutics
- Recruiting in
- St Louis
- Registry record
- NCT07065240 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Missouri on ClinicalTrials.gov.
Bipolar disorder: recently updated in Missouri
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- St Louis
- Registry record
- NCT06951711 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Missouri on ClinicalTrials.gov.
Parkinson's disease: recently updated in Missouri
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Recruiting in
- Springfield · St Louis
- Registry record
- NCT06989112 · updated
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Kansas City · Springfield
- Registry record
- NCT06345729 · updated
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- St Louis
- Registry record
- NCT06952504 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Kansas City · St Louis
- Registry record
- NCT06966700 · updated
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
- Phase 2
- Ages 50 to 80
- All sexes
- Sponsor
- Yale University
- Recruiting in
- St Louis
- Registry record
- NCT06996652 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Missouri on ClinicalTrials.gov.
Multiple sclerosis (MS): recently updated in Missouri
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- City of Saint Peters · Creve Coeur · Kansas City · and 2 more U.S. locations
- Registry record
- NCT03816345 · updated
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Recruiting in
- St Louis
- Registry record
- NCT07299019 · updated
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Recruiting in
- St Louis
- Registry record
- NCT07067463 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Missouri on ClinicalTrials.gov.
Migraine: recently updated in Missouri
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Recruiting in
- St Louis
- Registry record
- NCT06972056 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Missouri on ClinicalTrials.gov.
Ask about studies in Missouri
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections